PharmaReports: Pain
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focuses on the major pain etiologies. In addition reports relating to migraine and occasionally IBS will be found in this channel.
Showing results 51 - 95 of 95
- Postoperative Pain: Dynastat Cutting Up The Pain Market
- Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug Delivery
- Neuropathic Pain Insight - Life Beyond Gabapentin
- Stakeholder Insight: Osteoarthritis - COX-2s wear down traditional NSAID use
- Stakeholder Insight: Neuropathic Pain - Treatment Preferences Across the 7 Major Markets
- Stakeholder Insight: Fibromyalgia - Substantial Growth Opportunity for SNRI Antidepressants
- Stakeholder Insight: Diabetic Neuropathic Pain - Market Success is Not Limited to Pregabalin
- Stakeholder Insight: HIV Related Neuropathic Pain - Useful Niche for Peripheral Companies
- Stakeholder Insight: Neuropathic Low Back Pain - Off-label Revenue Despite Diagnostic Challenge
- Commercial Insight: Migraine - A Painful Future for the Triptans?
- Stakeholder Opinions: Migraine - Lots of Experience, But Less Expertise
- Innovations in CNS: Novel therapeutics and future R&D strategies
- The World Market for Pain Management Drugs and Devices: Applications and Top Products
- The U.S. Market for Over-the-Counter Pain Medication
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Neuropathic Pain - Emerging drugs fail to capitalize in lucrative market
- How to Conduct Clinical Trials in China
- The Anti-Migraine Market 2007-2022
- The Global Pain Pharmaceutical Market Analysis and Forecasts 2007-2022
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- The Pain Market Outlook to 2011
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008
- Outsourcing in Drug Discovery
- World OTC Pharmaceutical Markets
- The osteoarthritis market - COX-2 inhibibitors, NSAIDs and corticosteroids
- Neuronal Nicotinic Receptors - June 2008
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Pipeline and Commercial Insight: Neuropathic Pain
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Neuronal Nicotinic Receptors - July 2008
- Commercial and Pipeline Insight: Fibromyalgia
- Diagnostics in Neurology - Predictive biomarkers expand drug revenues
- Neuronal Nicotinic Receptors - August 2008
< Previous1 | 2
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development